Clinical Laboratory Services Market Size (2024 - 2029)

The clinical laboratory services market is projected to experience significant growth, driven by the increasing demand for accurate and early disease diagnosis techniques. The market's expansion is attributed to the rising incidence of chronic and infectious diseases, which has heightened the need for clinical diagnostics. Technological advancements and the launch of innovative diagnostic products are further expected to enhance market growth. Despite these positive trends, challenges such as stringent regulatory issues and a shortage of skilled labor may hinder the market's progress.

Market Size of Clinical Laboratory Services Industry

Clinical Laboratory Services Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 277.96 Billion
Market Size (2029) USD 380.65 Billion
CAGR (2024 - 2029) 6.49 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Clinical Laboratory Services Market Major Players

*Disclaimer: Major Players sorted in no particular order

Clinical Laboratory Services Market Analysis

The Clinical Laboratory Services Market size is estimated at USD 277.96 billion in 2024, and is expected to reach USD 380.65 billion by 2029, growing at a CAGR of 6.49% during the forecast period (2024-2029).

The COVID-19 pandemic impacted the clinical laboratory services market positively. Clinical diagnostics and technology, including molecular and serological testing for severe COVID-19 infections, increased globally during the pandemic. There was also an increase in rapid and widespread testing developments through improvements in clinical diagnostics and testing technology that helped increase the overall demand. For instance, in February 2021, Thermo Fisher Scientific launched the TaqPath COVID-19 HT Kit, which is for use on its automated amplitude platform, to increase its COVID-19 testing capacity by combining Thermo Fisher's extraction and real-time PCR instruments with liquid handling products from Tecan Group.

It has been observed that clinical laboratory services were largely used during the COVID-19 pandemic, which contributed to the growth of the market studied. Currently, the market studied has reached its pre-pandemic nature in terms of demand for services. It is expected that it will witness healthy growth shortly.

The rising incidence of chronic and infectious diseases and the increasing demand for accurate and early disease diagnosis techniques drive the market. The burden of infectious diseases and chronic disorders is constantly growing worldwide. As clinical diagnostic tests represent one of the most accurate methods for identifying and characterizing various biomarkers of chronic diseases and for detecting microorganisms, their demand is increasing with the rising burden of diseases such as cancer and tuberculosis (TB). For instance, according to an update from the WHO, about 10 million people globally had tuberculosis as of 2021, of which 5.6 million were men, 3.3 million were women, and 1.1 million were children. Due to the high burden of such diseases, the demand for clinical services is expected to increase, driving the growth of the market studied.

The growing burden of cancer is also expected to boost the demand for clinical diagnostics. For instance, according to Globocan Statistics 2020, there were 19.3 million new cases of cancer all over the world, accounting for both sexes, and the same source reported that the incidence of cancer is growing at a rapid pace globally. It is estimated that the number of new cancer cases in both sexes will reach 30.2 million by 2040.

Hence, owing to the increased burden of target diseases, market players are focusing on technological advancements for their products to have a competitive edge over the other players, which is expected to augment the growth of the market studied further. For instance, in July 2022, SRL Diagnostics launched the Fatty Liver Index for the diagnosis of non-alcoholic fatty liver disease. Thus, the launch of technologically advanced products, coupled with increased awareness about the early diagnosis of diseases, is anticipated to drive growth in the clinical laboratory services market.

However, stringent regulatory issues in various countries and the lack of skilled laborers are expected to restrain the market growth during the forecast period.

Clinical Laboratory Services Industry Segmentation

In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens to obtain information about the patient's health in order to aid in the diagnosis, prevention, and treatment of diseases.

The clinical laboratory services market has been segmented by test type (clinical chemistry, immunology, cytology, genetics, microbiology, hematology, and other test types), service provider (hospital-based laboratories and others, independent laboratories, and other service providers), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the abovementioned segments.

By Test Type
Clinical Chemistry
Immunology
Cytology
Genetics
Microbiology
Hematology
Other Test Types
By Service Provider
Hospital-based Laboratories and Others
Independent Laboratories
Other Service Providers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Clinical Laboratory Services Market Size Summary

The clinical laboratory services market is poised for significant growth, driven by the increasing incidence of chronic and infectious diseases and the rising demand for accurate and early diagnostic techniques. The market, which experienced a positive impact during the COVID-19 pandemic due to the surge in demand for clinical diagnostics and testing technologies, is expected to continue its upward trajectory. The burden of diseases such as cancer and tuberculosis is a major factor propelling the market, as clinical diagnostic tests are crucial for identifying and characterizing biomarkers and detecting microorganisms. Technological advancements and the launch of innovative products by market players further contribute to the market's expansion, with independent laboratories in developing regions like India and China capitalizing on the growing demand for medical diagnostic facilities.

In North America, the clinical laboratory services market is experiencing robust growth due to the presence of key players, government organizations, and a high burden of target and chronic diseases. The region benefits from increased awareness and accessibility of services, supported by strategic partnerships and acquisitions among major companies. The competitive landscape is marked by the presence of both global and local companies, with global players holding a significant market share. The market's competitiveness is expected to attract new entrants, further diversifying the landscape. Overall, the clinical laboratory services market is set to expand, driven by technological advancements, strategic collaborations, and the growing need for early disease diagnosis.

Explore More

Clinical Laboratory Services Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Technological Advancements in Clinical Testing

      2. 1.2.2 Rising Burden of Target Diseases and Growing Demand for Early Detection

    3. 1.3 Market Restraints

      1. 1.3.1 Regulatory Issues

      2. 1.3.2 Lack of Skilled Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Test Type

      1. 2.1.1 Clinical Chemistry

      2. 2.1.2 Immunology

      3. 2.1.3 Cytology

      4. 2.1.4 Genetics

      5. 2.1.5 Microbiology

      6. 2.1.6 Hematology

      7. 2.1.7 Other Test Types

    2. 2.2 By Service Provider

      1. 2.2.1 Hospital-based Laboratories and Others

      2. 2.2.2 Independent Laboratories

      3. 2.2.3 Other Service Providers

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Clinical Laboratory Services Market Size FAQs

The Clinical Laboratory Services Market size is expected to reach USD 277.96 billion in 2024 and grow at a CAGR of 6.49% to reach USD 380.65 billion by 2029.

In 2024, the Clinical Laboratory Services Market size is expected to reach USD 277.96 billion.

Clinical Laboratory Services Market Global - Industry Analysis, Size & Forecast Report (2024 - 2029)